We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.74B
AUM Growth
+$946M
Cap. Flow
+$105M
Cap. Flow %
1.56%
Top 10 Hldgs %
63.65%
Holding
393
New
188
Increased
79
Reduced
42
Closed
65

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$76M
2
NVO
Novo Nordisk
NVO
+$43.1M
3
FRPT icon
Freshpet
FRPT
+$41.5M
4
SBUX icon
Starbucks
SBUX
+$31.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$30.3M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$79.6M
2
PTCT icon
PTC Therapeutics
PTCT
+$76M
3
GRFS
Grifois
GRFS
+$50.6M
4
STAA icon
STAAR Surgical
STAA
+$47.2M
5
TVTX icon
Travere Therapeutics
TVTX
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 31.9%
2 Technology 5.53%
3 Consumer Discretionary 5.27%
4 Communication Services 2.01%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PII icon
376
Polaris
PII
$4.07B
– –
-178,000
Closed -$7.24M
QSR icon
377
Restaurant Brands International
QSR
$25.8B
– –
-124,391
Closed -$8.25M
RANI icon
378
Rani Therapeutics
RANI
$89M
– –
-3,151,354
Closed -$1.62M
RMTI icon
379
Rockwell Medical
RMTI
$28.2M
– –
-214,947
Closed -$1.82M
RRR icon
380
Red Rock Resorts
RRR
$3.62B
– –
-161,179
Closed -$8.39M
RVPH
381
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
– –
-134,600
Closed -$1.03M
SAM icon
382
Boston Beer
SAM
$1.92B
– –
-28,000
Closed -$5.34M
SBEV.WS
383
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
– –
-22,600
Closed -$486
SNEX icon
384
StoneX
SNEX
$7.94B
– –
-6,651
Closed -$269K
SNN icon
385
Smith & Nephew
SNN
$12.6B
– –
-522,038
Closed -$16M
SNTI icon
386
Senti Biosciences Holdings
SNTI
$11M
– –
-892,207
Closed -$1.88M
SRZN icon
387
Surrozen
SRZN
$297M
– –
-60,000
Closed -$536K
STAA icon
388
STAAR Surgical
STAA
$1.21B
– –
-2,812,000
Closed -$47.2M
THO icon
389
Thor Industries
THO
$4.14B
– –
-3,480
Closed -$309K
TSN icon
390
Tyson Foods
TSN
$20.4B
– –
-4,264
Closed -$239K
WKSP icon
391
Worksport
WKSP
$10.5M
– –
-246,548
Closed -$698K
MKZR
392
MacKenzie Realty Capital
MKZR
$3.7M
– –
-124,374
Closed -$833K
KMTS
393
Kestra Medical Technologies
KMTS
$1.55B
– –
-22,834
Closed -$379K
12 13 14 15
16

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Armistice Capital held 393 positions worth $6.74B, up 16% from $5.8B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Armistice Capital's Q3 2025 filing shows 188 new, 79 increased, 42 reduced and 65 closed positions. Its largest new stake was Novo Nordisk: 736,000 shares worth $40.8M. The largest sale was Supernus Pharmaceuticals, an estimated $79.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Armistice Capital's largest Q3 2025 buy was Novo Nordisk: 736,000 shares worth $40.8M.
  • Armistice Capital added most to Dentsply Sirona in Q3 2025, an estimated $76M increase.
  • Armistice Capital's biggest Q3 2025 reduction was Supernus Pharmaceuticals, cutting an estimated $79.6M.
  • Armistice Capital fully exited STAAR Surgical in Q3 2025, selling an estimated $47.2M.
  • Armistice Capital's ten largest holdings make up 64% of its $6.74B portfolio in Q3 2025.
  • Armistice Capital opened 188 new positions and closed 65 in Q3 2025.
  • Armistice Capital's portfolio value rose 16% quarter-over-quarter to $6.74B.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.